Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
5.16
-0.32 (-5.84%)
At close: Sep 5, 2025, 4:00 PM
5.15
-0.01 (-0.19%)
After-hours: Sep 5, 2025, 6:19 PM EDT
Apollomics Market Cap
Apollomics has a market cap or net worth of $11.07 million as of September 5, 2025. Its market cap has decreased by -23.30% in one year.
Market Cap
11.07M
Enterprise Value
2.26M
1-Year Change
-23.30%
Ranking
Category
Stock Price
$5.16
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $11.07M, a decrease of -91.45%. That is a compound annual growth rate of -47.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 5.69M | -47.04% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
| Nov 26, 2021 | 129.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |